3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Lymphoid
1
Genitourinary
1
Dermatologic
1
Breast
1
Conditions
Sarcoma
1
Multiple Myeloma
1
Melanoma
1
Lymphoma
1
Kidney Neoplasms
1
Breast Neoplasms
1
Interventions
fludarabine phosphate
4
Cyclophosphamide
4
Antilymphocyte Serum
4
Mycophenolic Acid
3
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Methotrexate
2
Filgrastim
2
Cyclosporine
2
Busulfan
2
thymoglobulin
1
sargramostim
1
orantinib
1
interferon-alfa-1b
1
fludarabine
1
cc-486
1
carfilzomib
1
aldesleukin
1
Whole-Body Irradiation
1
Voriconazole
1
Stem Cell Transplantation
1
Social Determinants of Health
1
Radiotherapy
1
Quality of Life
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Magnetic Resonance Spectroscopy
1
Interleukin-12 Subunit p35
1
Interferons
1
Interferon-alpha
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Interferons
×
Plasma cell
×
Clear all
NCT00276536
2015-10-14
IFNa
The Cleveland Clinic
Phase 1
Completed
35 enrolled